The findings also support the hypothesis that PR acquires the capacity to interact with the ER pathway in breast cancer, and that their combined action impacts on breast cancer development and progression, particularly where endogenous hormone cyclicity is disturbed, such as in peri-menopause and during HRT exposure. Here, PGR is linked to breast cancer.